Incheon, South Korea

Ju Hee Kang

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovative Contributions of Inventor Ju Hee Kang

Introduction: Ju Hee Kang, an accomplished inventor based in Incheon, South Korea, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Kang’s work primarily focuses on innovative compounds aimed at treating cancer. His latest inventions highlight his dedication to advancing medical research and treatment options.

Latest Patents: Kang's most recent patent involves the development of a heteroaryl derivative, specifically a 6-(isooxazolidin-2-yl)-N-phenylpyrimidin-4-amine derivative. This compound is not only innovative but also serves as a pharmaceutical composition designed for preventing or treating cancer. The patent explains that the compound exhibits high inhibitory activity against epidermal growth factor receptor (EGFR) variants, as well as wild-type or variants of ERBB2 and ERBB4. This remarkable inhibition suggests that the compound could be particularly useful in treating lung cancer, showing excellent activity against the proliferation of lung cancer cell lines.

Career Highlights: Ju Hee Kang works at Voronoi Inc., where he continues to focus on cutting-edge research in pharmaceuticals. His expertise and developments contribute substantially to the company's mission of enhancing cancer treatment options, thereby impacting patient lives positively.

Collaborations: At Voronoi Inc., Kang collaborates with notable colleagues, including Youn Ho Lee and Se In Kang. These partnerships are essential in fostering an environment of creativity and innovation, enabling significant advancements in their research pursuits.

Conclusion: Ju Hee Kang is a remarkable inventor who is making strides in the pharmaceutical field with his innovative compounds targeting cancer treatment. His latest patent demonstrates not only his technical expertise but also his commitment to improving healthcare outcomes. With ongoing research and collaboration, Kang continues to pave the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…